UNC-Lineberger Comprehensive Cancer Center: Combination Immunotherapy Before Surgery May Increase Survival in People With Head and Neck Cancer
March 26, 2025
March 26, 2025
CHAPEL HILL, North Carolina, March 26 -- The University of North Carolina Lineberger Comprehensive Cancer Center issued the following news:
* * *
Combination immunotherapy before surgery may increase survival in people with head and neck cancer
Researchers conducting a clinical trial of immunotherapy drugs for people with head and neck squamous cell carcinomas (HNSCCs) found that patients responded better to a combination of two immunotherapies than patient . . .
* * *
Combination immunotherapy before surgery may increase survival in people with head and neck cancer
Researchers conducting a clinical trial of immunotherapy drugs for people with head and neck squamous cell carcinomas (HNSCCs) found that patients responded better to a combination of two immunotherapies than patient . . .